CONTENT VALIDATION AND DISCLOSURES

Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

FACULTY — Drs Burstein, Geyer and Wolmark had no financial interests or affiliations to disclose. Dr Gralow — Consulting Agreements: Amgen Inc, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Roche Laboratories Inc, Sanofi-Aventis. Dr Greco — Advisory Committee: Bristol-Myers Squibb Company, Eli Lilly and Company; Paid Research: Eli Lilly and Company; Speakers Bureau: Eli Lilly and Company, GlaxoSmithKline. Dr Mackey — Honoraria: Amgen Inc, AstraZeneca Pharmaceuticals LP, Roche Laboratories Inc, Sanofi-Aventis. Dr Miller — Consulting Agreements: Eli Lilly and Company, Genentech BioOncology, Roche Laboratories Inc; Paid Research: Pfizer Inc, Roche Laboratories Inc; Speakers Bureau: Genentech BioOncology, Roche Laboratories Inc. Dr O’Shaughnessy — Consulting Agreements: Biogen Idec, GlaxoSmithKline; Speakers Bureau: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Bristol- Myers Squibb Company, Eli Lilly and Company, Sanofi-Aventis. Dr Perez — Paid Research: Bristol-Myers Squibb Company, Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals Corporation. Dr Piccart-Gebhart — Advisory Committee and Consulting Agreements: Bayer Pharmaceuticals Corporation, Bristol-Myers Squibb Company, GlaxoSmithKline, Novartis Pharmaceuticals Corporation, Onyx Pharmaceuticals Inc, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis. Dr Sledge — Consulting Fees: Genentech BioOncology; Contracted Research: Sanofi-Aventis. Dr Swain — Foundation Grant: Genentech BioOncology; Paid Research: Bristol-Myers Squibb Company; Paid Travel: Sanofi-Aventis.

EDITOR — Dr Love does not receive any direct remuneration from industry. Research To Practice receives funds in the form of educational grants to develop CME activities from the following commercial interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol-Myers Squibb Company, Celgene Corporation, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth.

RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

 

 

 

 

 

 

 

Home · Search

 

EDITOR'S NOTE
Bail Us Out
Neil Love, MD

CLINICAL TRIALS

Neoadjuvant Therapy

Adjuvant Therapy

Metastatic Disease

Breast Cancer
Clinical Trials Guide:
A CME Audio Series and Activity

Faculty Disclosures

Editor's Office